Skip to main content

Our People

Our Board

Alesi Surgical combines product development expertise, commercial acumen and practical experience of issues faced by surgical teams.

Dominic Griffiths - CEO

Dominic has extensive experience in the creation, commercialisation and management of Life Science companies and products. This was gained through investment, commercial and strategy roles with Fusion IP PLC, Phoqus Pharmaceuticals PLC and Gemini Consulting. He co-founded Alesi Surgical in 2009 whilst he was Portfolio Investor Director of Fusion IP PLC (since acquired by IP Group PLC).

David Frederick - Chairman

David was previously VP of Sales for Covidien where he had responsibility for over $1bn in sales. He is currently Managing Director of Healthcare 21 Limited, a multinational medical device distribution company.

Alessio Beverina - Investor Director

Alessio is co-founder and General partner of a new VC firm, Panakes Partners, headquartered in Milan-Italy. Panakes finances medical companies with focus on the medical device, diagnostics and healthcare IT fields. Its portfolio in Europe and Israel, has early stage startup and SMEs, with extremely promising products and great ambition, Alessio has 9 years of VC experience in Sofinnova Partners, one of the largest European VCs, grown internally from Analyst to Partner positions, with European and American exposure. Alessio is a Kauffman Fellow.

Peter Grant - Investor Director

Peter is a serial Life Sciences entrepreneur and was co-founder and Operations Director of Fusion IP PLC. Following its acquisition by IP Group PLC, he now heads up the Group’s New Business & Partnerships division. Peter has previously worked at Genzyme UK Limited; Celltech Limited; Enzymatix Limited and Celsis plc, which he co-founded and took to a full listing on the London Stock Exchange.

Phil Cooper - Non-Executive Director

Phil Cooper has 29 years’ experience in the medical device industry. Phil spent the majority of his executive career at SCA Molnlycke and Molnlycke Health Care. Phil’s last role was as President of the Wound Care Division and Executive Board member. Previously he held roles as Global Sales Operations Director – Wound Care, and UK Managing Director.

Thom Rasche - Investor Director

Thom has more than 15 years’ experience as an investor. Further, he is a seasoned executive in the medical device and diagnostic sectors with over 28 years of operational experience. Since he joined Earlybird, Thom has been responsible for the medical device portfolio and new investments in this area. He is currently on the board of EBS Technologies GmbH (Berlin), Miracor Medical Systems GmbH (Vienna), Atlantic Therapeutics Ltd. (Galway) and Alesi Surgical Ltd. (Cardiff). Before joining Earlybird, Thom was with Johnson & Johnson Medical Devices and Diagnostics group in various international senior management roles, lastly as Managing Director for Ethicon-Endo-Surgery, Germany. Thom Rasche holds a Degree as Diplom Kaufmann (MBA equivalent) from the University of Applied Sciences in Lüneburg, Germany.

Dominic Griffiths

Dominic Griffiths - CEO

Dominic has extensive experience in the creation, commercialisation and management of Life Science companies and products. This was gained through investment, commercial and strategy roles with Fusion IP PLC, Phoqus Pharmaceuticals PLC and Gemini Consulting. He co-founded Alesi Surgical in 2009 whilst he was Portfolio Investor Director of Fusion IP PLC (since acquired by IP Group PLC).

David Frederick

David Frederick - Chairman

David was previously VP of Sales for Covidien where he had responsibility for over $1bn in sales. He is currently Managing Director of Healthcare 21 Limited, a multinational medical device distribution company.

Alessio Beverina

Alessio Beverina - Investor Director

Alessio is co-founder and General partner of a new VC firm, Panakes Partners, headquartered in Milan-Italy. Panakes finances medical companies with focus on the medical device, diagnostics and healthcare IT fields. Its portfolio in Europe and Israel, has early stage startup and SMEs, with extremely promising products and great ambition, Alessio has 9 years of VC experience in Sofinnova Partners, one of the largest European VCs, grown internally from Analyst to Partner positions, with European and American exposure. Alessio is a Kauffman Fellow.

Peter Grant

Peter Grant - Investor Director

Peter is a serial Life Sciences entrepreneur and was co-founder and Operations Director of Fusion IP PLC. Following its acquisition by IP Group PLC, he now heads up the Group’s New Business & Partnerships division. Peter has previously worked at Genzyme UK Limited; Celltech Limited; Enzymatix Limited and Celsis plc, which he co-founded and took to a full listing on the London Stock Exchange.

Phil Cooper

Phil Cooper - Non-Executive Director

Phil Cooper has 29 years’ experience in the medical device industry. Phil spent the majority of his executive career at SCA Molnlycke and Molnlycke Health Care. Phil’s last role was as President of the Wound Care Division and Executive Board member. Previously he held roles as Global Sales Operations Director – Wound Care, and UK Managing Director.

Thom Rasche

Thom Rasche - Investor Director

Thom has more than 15 years’ experience as an investor. Further, he is a seasoned executive in the medical device and diagnostic sectors with over 28 years of operational experience. Since he joined Earlybird, Thom has been responsible for the medical device portfolio and new investments in this area. He is currently on the board of EBS Technologies GmbH (Berlin), Miracor Medical Systems GmbH (Vienna), Atlantic Therapeutics Ltd. (Galway) and Alesi Surgical Ltd. (Cardiff). Before joining Earlybird, Thom was with Johnson & Johnson Medical Devices and Diagnostics group in various international senior management roles, lastly as Managing Director for Ethicon-Endo-Surgery, Germany. Thom Rasche holds a Degree as Diplom Kaufmann (MBA equivalent) from the University of Applied Sciences in Lüneburg, Germany.